» Articles » PMID: 12957286

Tumor Induction by an Endogenous K-ras Oncogene is Highly Dependent on Cellular Context

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2003 Sep 6
PMID 12957286
Citations 272
Authors
Affiliations
Soon will be listed here.
Abstract

We have targeted a K-ras allele in mouse embryonic stem (ES) cells to express a K-Ras(V12) oncoprotein along with a marker protein (beta-geo) from a single bicistronic transcript. Expression of this oncogenic allele requires removal of a knocked in STOP transcriptional cassette by Cre recombinase. Primary mouse embryonic fibroblasts expressing this K-ras(V12) allele do not undergo proliferative senescence and proliferate as immortal cells. In mice, expression of K-ras(V12) throughout the body fails to induce unscheduled proliferation or other growth abnormalities for up to eight months. Only a percentage of K-ras(V12)-expressing lung bronchiolo-alveolar cells undergo malignant transformation leading to the formation of multiple adenomas and adenocarcinomas. These results indicate that neoplastic growth induced by an endogenous K-ras oncogene depends upon cellular context.

Citing Articles

Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses.

Lesbats J, Brillac A, Reisz J, Mukherjee P, Lhuissier C, Fernandez-Monreal M Nature. 2025; .

PMID: 40011782 DOI: 10.1038/s41586-025-08629-4.


TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.

Anand J, Droby G, Joseph S, Patel U, Zhang X, Klomp J bioRxiv. 2025; .

PMID: 39975297 PMC: 11838190. DOI: 10.1101/2025.01.26.634889.


Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models.

Li D, Geng K, Hao Y, Gu J, Kumar S, Olson A J Clin Invest. 2024; 135(2.

PMID: 39718828 PMC: 11735103. DOI: 10.1172/JCI174249.


Inhibition of lung tumorigenesis by transient reprogramming in cancer cells.

Pedrosa P, Zhang Z, Nunez-Quintela V, Macias D, Ge J, Denholm M Cell Death Dis. 2024; 15(11):857.

PMID: 39587064 PMC: 11589828. DOI: 10.1038/s41419-024-07207-2.


Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.

Fernandez-Garcia F, Fernandez-Rodriguez A, Fustero-Torre C, Pineiro-Yanez E, Wang H, Lechuga C Proc Natl Acad Sci U S A. 2024; 121(36):e2402913121.

PMID: 39186651 PMC: 11388366. DOI: 10.1073/pnas.2402913121.